These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28646291)

  • 1. Application of open-access databases to determine functional connectivity between resveratrol-binding protein QR2 and colorectal carcinoma.
    Doonan BB; Schaafsma E; Pinto JT; Wu JM; Hsieh TC
    In Vitro Cell Dev Biol Anim; 2017 Aug; 53(7):575-578. PubMed ID: 28646291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular biomarkers and classification models in the evaluation of the prognosis of colorectal cancer.
    Sideris M; Papagrigoriadis S
    Anticancer Res; 2014 May; 34(5):2061-8. PubMed ID: 24778007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of p21 (CDKN1A/CIP1) is inversely associated with microsatellite instability and CpG island methylator phenotype (CIMP) in colorectal cancer.
    Ogino S; Kawasaki T; Kirkner GJ; Ogawa A; Dorfman I; Loda M; Fuchs CS
    J Pathol; 2006 Oct; 210(2):147-54. PubMed ID: 16850502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation.
    Lee S; Cho NY; Choi M; Yoo EJ; Kim JH; Kang GH
    Pathol Int; 2008 Feb; 58(2):104-13. PubMed ID: 18199160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
    Kim JH; Bae JM; Cho NY; Kang GH
    Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer.
    Goel A; Nagasaka T; Arnold CN; Inoue T; Hamilton C; Niedzwiecki D; Compton C; Mayer RJ; Goldberg R; Bertagnolli MM; Boland CR
    Gastroenterology; 2007 Jan; 132(1):127-38. PubMed ID: 17087942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of quinone reductase 2 in complex with resveratrol.
    Buryanovskyy L; Fu Y; Boyd M; Ma Y; Hsieh TC; Wu JM; Zhang Z
    Biochemistry; 2004 Sep; 43(36):11417-26. PubMed ID: 15350128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, biological and structural evaluation of functionalized resveratrol analogues as inhibitors of quinone reductase 2.
    St John SE; Jensen KC; Kang S; Chen Y; Calamini B; Mesecar AD; Lipton MA
    Bioorg Med Chem; 2013 Oct; 21(19):6022-37. PubMed ID: 23953689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18q loss of heterozygosity in microsatellite stable colorectal cancer is correlated with CpG island methylator phenotype-negative (CIMP-0) and inversely with CIMP-low and CIMP-high.
    Ogino S; Kawasaki T; Kirkner GJ; Ohnishi M; Fuchs CS
    BMC Cancer; 2007 May; 7():72. PubMed ID: 17474983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer.
    Mármol I; Sánchez-de-Diego C; Pradilla Dieste A; Cerrada E; Rodriguez Yoldi MJ
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative telomere lengths in tumor and normal mucosa are related to disease progression and chromosome instability profiles in colorectal cancer.
    Suraweera N; Mouradov D; Li S; Jorissen RN; Hampson D; Ghosh A; Sengupta N; Thaha M; Ahmed S; Kirwan M; Aleva F; Propper D; Feakins RM; Vulliamy T; Elwood NJ; Tian P; Ward RL; Hawkins NJ; Xu ZZ; Molloy PL; Jones IT; Croxford M; Gibbs P; Silver A; Sieber OM
    Oncotarget; 2016 Jun; 7(24):36474-36488. PubMed ID: 27167335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular pathways in colorectal cancer.
    Al-Sohaily S; Biankin A; Leong R; Kohonen-Corish M; Warusavitarne J
    J Gastroenterol Hepatol; 2012 Sep; 27(9):1423-31. PubMed ID: 22694276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty acid synthase overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype.
    Ogino S; Kawasaki T; Ogawa A; Kirkner GJ; Loda M; Fuchs CS
    Hum Pathol; 2007 Jun; 38(6):842-9. PubMed ID: 17350669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the CpG island methylator phenotype in colorectal cancer prognosis depends on microsatellite instability screening status.
    Dahlin AM; Palmqvist R; Henriksson ML; Jacobsson M; Eklöf V; Rutegård J; Oberg A; Van Guelpen BR
    Clin Cancer Res; 2010 Mar; 16(6):1845-55. PubMed ID: 20197478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency.
    Dawson H; Galván JA; Helbling M; Muller DE; Karamitopoulou E; Koelzer VH; Economou M; Hammer C; Lugli A; Zlobec I
    Int J Cancer; 2014 May; 134(10):2342-51. PubMed ID: 24166180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of CpG island methylator phenotype (CIMP)-high, -low, and -negative colorectal cancers based on protein marker expression and molecular features.
    Zlobec I; Bihl M; Foerster A; Rufle A; Lugli A
    J Pathol; 2011 Nov; 225(3):336-43. PubMed ID: 21660972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No association of CpG island methylator phenotype and colorectal cancer survival: population-based study.
    Jia M; Jansen L; Walter V; Tagscherer K; Roth W; Herpel E; Kloor M; Bläker H; Chang-Claude J; Brenner H; Hoffmeister M
    Br J Cancer; 2016 Nov; 115(11):1359-1366. PubMed ID: 27811854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTGER2 overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype.
    Baba Y; Nosho K; Shima K; Goessling W; Chan AT; Ng K; Chan JA; Giovannucci EL; Fuchs CS; Ogino S
    Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):822-31. PubMed ID: 20200425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathways of colorectal carcinogenesis.
    Arends MJ
    Appl Immunohistochem Mol Morphol; 2013 Mar; 21(2):97-102. PubMed ID: 23417071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic and molecular features of sporadic microsatellite- and chromosomal-stable colorectal cancers.
    Cai G; Xu Y; Lu H; Shi Y; Lian P; Peng J; Du X; Zhou X; Guan Z; Shi D; Cai S
    Int J Colorectal Dis; 2008 Apr; 23(4):365-73. PubMed ID: 18193434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.